Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-alpha-phellandrene | increases expression | ISO | PABIR2 (Homo sapiens) | 6480464 | alpha phellandrene results in increased expression of PABIR2 mRNA | CTD | PMID:25075043 | (1->4)-beta-D-glucan | multiple interactions | ISO | Pabir2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FAM122B mRNA | CTD | PMID:36331819 | 1,2-dichloroethane | decreases expression | ISO | Pabir2 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of PABIR2 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | decreases expression | ISO | Pabir2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of PABIR2 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | Pabir2 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of PABIR2 mRNA] | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | PABIR2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PABIR2 mRNA | CTD | PMID:22574217 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PABIR2 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Pabir2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PABIR2 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PABIR2 mRNA | CTD | PMID:33387578 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | Pabir2 (Mus musculus) | 6480464 | tetrabromobisphenol A results in decreased expression of PABIR2 mRNA | CTD | PMID:25172293 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Pabir2 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of PABIR2 mRNA | CTD | PMID:26251327 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of PABIR2 mRNA | CTD | PMID:28959563 | aflatoxin B1 | affects expression | ISO | PABIR2 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of PABIR2 protein | CTD | PMID:20106945 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of PABIR2 mRNA | CTD | PMID:20488242 | alpha-phellandrene | increases expression | ISO | PABIR2 (Homo sapiens) | 6480464 | alpha phellandrene results in increased expression of PABIR2 mRNA | CTD | PMID:25075043 | antirheumatic drug | decreases expression | ISO | PABIR2 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of PABIR2 mRNA | CTD | PMID:24449571 | arsenite(3-) | decreases expression | ISO | Pabir2 (Mus musculus) | 6480464 | arsenite results in decreased expression of PABIR2 mRNA | CTD | PMID:18929588 | benzo[a]pyrene | affects methylation | ISO | PABIR2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of PABIR2 5' UTR and Benzo(a)pyrene affects the methylation of PABIR2 promoter | CTD | PMID:27901495 | bisphenol A | increases expression | ISO | PABIR2 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of PABIR2 mRNA | CTD | PMID:25047013 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of PABIR2 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PABIR2 mRNA | CTD | PMID:33296240 | cadmium atom | decreases expression | ISO | PABIR2 (Homo sapiens) | 6480464 | Cadmium results in decreased expression of PABIR2 mRNA | CTD | PMID:21297354 and PMID:24376830 | caffeine | affects phosphorylation | ISO | PABIR2 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of PABIR2 protein | CTD | PMID:35688186 | copper(II) sulfate | increases expression | ISO | PABIR2 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of PABIR2 mRNA | CTD | PMID:19549813 | coumarin | affects phosphorylation | ISO | PABIR2 (Homo sapiens) | 6480464 | coumarin affects the phosphorylation of PABIR2 protein | CTD | PMID:35688186 | coumestrol | increases expression | ISO | PABIR2 (Homo sapiens) | 6480464 | Coumestrol results in increased expression of PABIR2 mRNA | CTD | PMID:19167446 | dorsomorphin | multiple interactions | ISO | PABIR2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PABIR2 mRNA | CTD | PMID:27188386 | doxorubicin | increases expression | ISO | Pabir2 (Mus musculus) | 6480464 | Doxorubicin results in increased expression of PABIR2 mRNA | CTD | PMID:36227756 | folic acid | multiple interactions | ISO | Pabir2 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of PABIR2 mRNA] | CTD | PMID:22206623 | folic acid | decreases expression | ISO | Pabir2 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of PABIR2 mRNA | CTD | PMID:25629700 | FR900359 | affects phosphorylation | ISO | PABIR2 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of PABIR2 protein | CTD | PMID:37730182 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of PABIR2 mRNA | CTD | PMID:33387578 | hydrogen peroxide | increases expression | ISO | PABIR2 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in increased expression of PABIR2 mRNA | CTD | PMID:18951874 | inulin | multiple interactions | ISO | Pabir2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FAM122B mRNA | CTD | PMID:36331819 | methyl methanesulfonate | decreases expression | ISO | PABIR2 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of PABIR2 mRNA | CTD | PMID:23649840 | methylmercury chloride | increases expression | ISO | PABIR2 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of PABIR2 mRNA | CTD | PMID:28001369 | oxaliplatin | multiple interactions | EXP | | 6480464 | [Oxaliplatin co-treated with Topotecan] results in decreased expression of PABIR2 mRNA | CTD | PMID:25729387 | ozone | multiple interactions | ISO | Pabir2 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in increased expression of PABIR2 mRNA | CTD | PMID:34911549 | paracetamol | increases expression | ISO | PABIR2 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of PABIR2 mRNA | CTD | PMID:22230336 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of PABIR2 mRNA | CTD | PMID:33387578 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Pabir2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FAM122B mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FAM122B mRNA | CTD | PMID:36331819 | phenylmercury acetate | decreases expression | ISO | PABIR2 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of PABIR2 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | PABIR2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PABIR2 mRNA | CTD | PMID:27188386 | pirinixic acid | decreases expression | ISO | Pabir2 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of PABIR2 mRNA | CTD | PMID:20813756 | quercetin | increases expression | ISO | PABIR2 (Homo sapiens) | 6480464 | Quercetin results in increased expression of PABIR2 mRNA | CTD | PMID:21632981 | SB 431542 | multiple interactions | ISO | PABIR2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PABIR2 mRNA | CTD | PMID:27188386 | sodium arsenite | decreases expression | ISO | Pabir2 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of PABIR2 mRNA | CTD | PMID:36209798 | sunitinib | decreases expression | ISO | PABIR2 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of PABIR2 mRNA | CTD | PMID:31533062 | testosterone | decreases expression | ISO | PABIR2 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of PABIR2 mRNA | CTD | PMID:33359661 | tetrachloromethane | increases expression | ISO | Pabir2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of PABIR2 mRNA | CTD | PMID:31919559 | topotecan | multiple interactions | EXP | | 6480464 | [Oxaliplatin co-treated with Topotecan] results in decreased expression of PABIR2 mRNA | CTD | PMID:25729387 | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of PABIR2 mRNA | CTD | PMID:25729387 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of PABIR2 mRNA | CTD | PMID:33387578 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of PABIR2 mRNA | CTD | PMID:33387578 | trimellitic anhydride | increases expression | ISO | Pabir2 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of PABIR2 mRNA | CTD | PMID:19042947 | triptonide | decreases expression | ISO | Pabir2 (Mus musculus) | 6480464 | triptonide results in decreased expression of PABIR2 mRNA | CTD | PMID:33045310 | triticonazole | increases expression | EXP | | 6480464 | triticonazole results in increased expression of PABIR2 mRNA | CTD | PMID:36084822 | trovafloxacin | decreases expression | ISO | Pabir2 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of PABIR2 mRNA | CTD | PMID:35537566 | valproic acid | affects expression | ISO | PABIR2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of PABIR2 mRNA | CTD | PMID:23179753 | valproic acid | increases expression | ISO | PABIR2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of PABIR2 mRNA | CTD | PMID:28001369 and PMID:29154799 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of PABIR2 mRNA | CTD | PMID:22570695 | |